CEO Sales vs. Whale Wallets: The Real Signal in Insider Trading

The real signal isn't in the hype; it's in the filings. When a CEO sells their own stock, it's the ultimate test of skin in the game. Recent actions from two high-profile leaders suggest they're taking money off the table, a move that often precedes caution.

On February 3, President and CEO Thomas E. Ferguson of AZZ sold 25,000 shares for an estimated $3.18 million. That wasn't a minor trim. The transaction represented 13.6% of his class of stock, a substantial portion of his direct stake. This sale followed a pattern of heavy insider selling at AZZ, with no purchases from insiders in the past six months. It's a stark contrast to the institutional picture, where some funds are buying while others are selling. But the CEO's move is the clearest alignment signal.

A similar pattern emerged at CareDx. President and CEO John Walter Hanna Jr. sold 19,480 shares for a total value of approximately $412,200 in January. While the sale was part of a pre-planned Rule 10b5-1 plan, its size was notable-it was larger than his typical transaction and his median sell size. This wasn't a routine, small-scale exit.

This isn't isolated. These CEO sales align with a broader, more telling trend. In January, insiders were heavy sellers across the board, with high-flyers like CoreWeave and Urban Outfitters seeing significant outflows. This wave of selling coincides with technical market tops that capped gains in 2025. When smart money, including those with the deepest pockets and longest view, starts taking profits, it's a stronger signal than any isolated executive buy.

The bottom line is that recent CEO sales, even if not massive, are a more reliable warning sign than bullish analyst reports or institutional noise. When the person running the company is selling, it's time to ask what they know that the market doesn't.

Institutional Accumulation: A Divergent Signal

While CEO selling paints a picture of internal caution, the institutional picture tells a more complex story. Some whales are buying, but their moves often lack the direct alignment of interest that comes from a company's own leadership. The divergence is clear.

Take Carrier Global. Here, we see a rare alignment. Chairman and CEO David L. Gitlin has been buying shares, a direct vote of confidence. This insider buying is being matched by major institutional funds like PineStone Asset Management and UBS Asset Management, which have expanded their holdings. In this case, the smart money is moving in lockstep. It's a bullish counter-narrative that suggests some large players see value in the company's long-term climate solutions story, even as they watch for near-term earnings pressure.

But this is the exception. More often, institutional accumulation looks like a separate, strategic move. In late January, Manufacturers Life Reinsurance Ltd purchased nearly 2 million shares of John Hancock Senior Loan Trust for $32 million. This was a massive, one-time accumulation by a single entity, not a reflection of internal sentiment at the trust itself. It's the kind of whale wallet move that can support a price, but it doesn't signal the same skin-in-the-game commitment as a CEO buying his own stock.

The broader pattern is one of conflicting signals. Some institutional funds are buying, providing a floor for certain names. Yet this activity is happening alongside a wave of CEO sales at prominent companies like AZZ and CareDx. The institutional buying offers a bullish counter-narrative, but it's not a substitute for the internal alignment signal. When the person running the company is selling, it's a more direct read on what they know about the near-term path. In the tug-of-war between insider selling and institutional accumulation, the CEO's hand is the one that matters most.

Catalysts and Risks: What to Watch Next

The thesis from the insider flows is clear: caution is the dominant tone. But for that narrative to hold, we need to watch a few key catalysts and risks unfold. The next few weeks will confirm whether this selling is a temporary profit-taking or the start of a broader capitulation.

First, watch for any reversal in the CEO selling trend. A sustained pause or, better yet, a shift to buying by leaders like Thomas Ferguson at AZZ or John Hanna at CareDx would be a powerful bullish signal. Right now, the pattern is one of heavy selling with no purchases from insiders at AZZ in the past six months. If that changes, it would directly contradict the current skin-in-the-game test. For now, the trend is the signal.

Second, the February 5 earnings report for Carrier Global is a critical data point. This report, which will detail its fourth quarter 2025 results, is the most relevant near-term catalyst for the stock. It should provide updated detail on regional performance, margins, and progress in higher-margin aftermarket services. In the context of the recent insider and institutional activity, that update will frame how investors weigh the existing bullish narrative-driven by climate solutions and smart building tech-against near-term headwinds like soft demand in certain international markets. The guidance on those pressures will be key.

The overarching risk, however, is that insider selling, even if not massive, aligns with technical market tops and could cap gains. This isn't just about a few CEOs selling; it's part of a broader, more telling trend. In January, insiders were heavy sellers across the board, with high-flyers like CoreWeave and Urban Outfitters seeing significant outflows. This wave of selling coincides with technical market tops that capped gains in 2025. When the smart money, including those with the deepest pockets and longest view, starts taking profits, it's a stronger signal than any isolated executive buy. The risk is that this pattern continues, pressuring markets and limiting upside as we move through 2026.